Trial
NCT02820519
Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
University of Witten/Herdecke
Collaborators
—
Condition
Neuropathic Pain
Intervention
Loxapine
Why stopped
Intolerable high amount of adverse events
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-07-01